On February 7, during the Connext event, organized by Confindustria at the MiCo in Milan, the ceremony for the presentation of the IxI Confindustria “Enterprise for Innovation” Award was held.
Farmalabor collects the fourth consecutive award and is confirmed among the 12 Italian companies that in 2018 have invested with concrete results on research, growth and development.
In this edition, Farmalabor also won the Prize of Prizes, instituted by the Presidency of the Council of Ministers on behalf of the President of the Republic and intended for 9 of the 12 winning companies.
The Confindustria “Imprese per l’Innovazione” Award, realized in collaboration with the Giuseppina Mai Foundation, Confindustria Bergamo, with the support of BNP Paribas and the technical support of the Associazione Premio Qualità Italia (APQI), stands out for being the first in Europe to have adopted the parameters of the European Foundation for Quality Management (EFQM) for the certification of innovation.
“The element that convinced the jury was our management of processes related to innovation – confirms Dr. Antonio Pepe, Director of the Farmalabor Study and Research Centre – from the laboratory phase to the creation of the finished product. Through this scheme, we are carrying out research & development projects, especially in the nutraceutical field, to meet the needs of health and wellness in a new, unique way. In our vision, the drug will be more and more personalized”.
And it is precisely the concept of “personalized medicine” that is at the heart of Farmalabor’s future strategies. “In the coming years – says Dr. Sergio Fontana, CEO – the pharmaceutical industry will be invested in a process of technological and productive renewal, tailored to the patient. As a company, we are working to test the production of on-demand drugs with 3D printers, with which pharmacists can quickly set up a customized drug in form and dosage. Obviously, an important support to our innovation policy comes from the area of organization and marketing association of Confindustria Bari and BAT, always in the front line next to SMEs that look far away.